Eric J. Avery, M.D.

Dr. Eric J. Avery, M.D.

"As Nebraska's first QOPI certified clinic, NHO is among the region's leaders in high-quality patient-centered cancer care. Our commitment to each patient and the desire for individualized treatment is what makes NHO unique."

  • Undergraduate degree, Doane College, Bachelor of Science with Honors in Biology
  • Graduate, University of Nebraska Medical Center College of Medicine
  • Honored as UNMC Rookie of the Year, 2007
  • Earned UNMC Senior Resident Award, 2009
  • Completed Residency in Internal Medicine, University of Nebraska Medical Center, 2009
  • Completed Fellowship, University of Nebraska Medical Center; Hematology/Oncology, 2012
  • Board Certified Internal Medicine
  • Board Certified Hematology and Medical Oncology
  • Joined Nebraska Hematology-Oncology in August, 2012

Madhu V. Midathada, M.D.

“We strive to develop the optimum treatment strategy for each person based on their medical background, current health, and personal preferences. Everything we do is individualized to offer the best outcome possible.”

  • Graduate, Andhra Medical College, University of Health Sciences, Visakhapatnam, India, 1992
  • Completed Rotational Internship, King George Hospital, Visakhapatnam, India, 1994
  • Completed Residency in Internal Medicine, Coney Island Hospital, SUNY Health Science Center, New York, 2002
  • Completed Fellowship in Hematology-Oncology, University of Arkansas for Medical Sciences, 2005
  • Merit Award Winner, American Society of Clinical Oncology, 2004 and 2005
  • Board Certified Internal Medicine
  • Board Certified Hematology and Medical Oncology
  • Broad research background in hematology and oncology at UAMS and in laboratory medicine at Centers for Disease Control, Atlanta
  • Published scientific papers in American Society of Clinical Oncology, American Journal of Clinical Pathology, Journal of Infectious Diseases, and Clinical Advances in Hematology & Oncology
  • In practice since 2005

Joni A. Tilford, M.D.

“Our ongoing involvement in clinical trials keeps us in tune with the latest advancements in cancer care. The people we treat deserve the best, and we make sure they get it.”

  • Undergraduate degree, Nebraska Wesleyan University, 1991, BS in Biology with Math minor
  • Graduate, University of Nebraska School of Medicine, 1997
  • Completed Residency in Internal Medicine, University of Nebraska Medical Center, 2000
  • Completed Fellowship in Hematology-Oncology, University of Nebraska Medical Center, 2002
  • Board Certified Medical Oncology
  • Dr. Tilford has a broad background in both clinical and laboratory medicine and has authored scientific articles in molecular genetics, thrombosis, and leukemia.
  • In practice since 2002

Mark R. Hutchins, M.D.

“Caring for each individual, as a unique person, is as important to me as treating the disease.”

  • Undergraduate degree with Distinction, University of Nebraska, Lincoln: Member Phi Beta Kappa, 1974
  • Graduate, University of Nebraska School of Medicine, 1976
  • Completed Residency in Internal Medicine, University of Oklahoma, 1979
  • Completed Fellowship in Hematology-Oncology, University of Oklahoma, 1981
  • Board Certified Internal Medicine Board Certified Medical Oncology In practice since 1981

Daniel F. Moravec, Jr., M.D

Dr. Daniel Moravec recently retired from Nebraska Hematology-Oncology. He has been a vital part of this practice for nearly 30 years and will be missed. We celebrate his accomplishments and the passion and dedication he has provided to many over the years.

“It has been my pleasure for more than 30 years to work with the outstanding physicians and staff within the Lincoln medical community. I very much appreciate all of the good things that we have accomplished together. Most of all, I am grateful for all of the positive results that have been provided for all of our patients, a major hallmark of the physicians and staff at NHO.

My colleagues at Nebraska Hematology-Oncology look forward to the opportunity to provide exceptional, personal care to our patients.”